Question What is a public policy meeting? A meeting held by public or governmental officials to discuss and deal with public problems or issues, communicate and disseminate information, and engage in problem-solving, policy change strategizing and/or decision making. Open public policy meetings are when the public’s business is conducted in open, noticed meetings, where the public, lobbyists and members of the news media have the right to attend, record, broadcast, and in some cases participate in the meeting. An open meeting agenda is usually posted in advance and meeting materials may be made available.

Public Policy Meeting on Alzheimer’s Disease

Name
Institution Affiliation
Course Number
Instructor
Date

 
Hello Professor,
16th December 2020: Location: Online meeting
Name: Senate Hearing on Alzheimer’s Disease
The Senate Finance Subcommittee on Healthcare conducted a public meeting on the disease pathologies and financial impact of Alzheimer’s disease on the American people.
C-Span.orgLink: – https://www.c-span.org/video/?507328-1/senate-hearing-alzheimers-disease
Discussions on Alzheimer’s Research and Treatment Financing
The meeting was an online senate hearing that took place on 16th December 2020. The various members of the senate finance subcommittee on healthcare, and the professional invited to contribute, attended the meeting from various geographical locations via an online meeting platform. Senator Pat Toomey, the subcommittee chair, introduces the public policy meeting by stating that Alzheimer’s disease has been a challenge to the healthcare system, mainly in finance. The disease is quite fatal, and Senator Pat adds that no therapeutic approach can stop or handle this disease once an individual is exposed to it. As Senator Pat Toomey states, “according to a study by the National Institute of Ageing, the annual cost of dementia is approximated to be over 379 billion annually, by the year 2040” (01:41). The greatest obstacle in the desire to make progress lies in the fact that the relevant healthcare and research bodies dealing with Alzheimer’s and other mental health conditions do not receive their fair share of funding. There being rapid and accurate testing can help diagnose the disease early enough, thus preventing neurological decay of the patient.
Mental disorders tend to challenge dealing with them as they are commonly irreversible and expensive to provide care. According to Dr. Nikolay Dokholyan, Alzheimer’s is a progressive, irreversible and degenerative brain disease. He is a participant in the public policy meeting and a significant and vital contributor; he is also a professor of pharmacology at Penn State University. Although much effort has been put into managing it, rural folks have been left far behind as their access to proper healthcare facilities specialized in mental health disorders is limited.
Incorporating machine learning and artificial intelligence can help spearhead the search for better diagnostics and more affordable treatment options. Dr. Randall Bateman adds that, with adequate funding, these can be easily achieved as the industry players would efficiently work in collaboration to handle the disease pathologies. Maria Carrillo adds that “Stays in hospitals are four times higher and several times costlier for thus disorders as compared to many other diseases. Thus, early intervention and better management practices can help reduce the cost burden for patients.” 53:54

Order this paper